Goldman Sachs Initiates Amsurg At Buy

Goldman Sachs initiated coverage on Amsurg Corp AMSG with a Buy rating. The target price for Amsurg is set to $81. Amsurg shares have gained 35.64 percent over the past 52 weeks, while the S&P 500 index has surged 7.51 percent in the same period. Amsurg shares closed at $68.51 yesterday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: InitiationAnalyst RatingsGoldman Sachs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!